Search | Page 30 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s ... (SCT) between 3 to 15 months after the SCT. In this research study, researchers want to find how well dasatinib can be tolerated, ...

    Clinical Trial last updated 05/03/2016 - 10:43am.

  2. Prognostic value of telomere attrition in patients with aplastic anemia

    ... measurements are another example of a potentially useful clinical marker to predict outcome in patients with SAA.  Telomeres are ... is ongoing.    In summary, it is an active area of research to utilize TL measurements in the decision making for patients with ...

    Research Review last updated 05/02/2016 - 9:25am.

  3. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  This research is being done to learn more about nonmyeloablative bone marrow ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  4. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  This research is looking at two conditions, Essential Thrombocythemia (ET) and ...

    Clinical Trial last updated 05/02/2016 - 2:31pm.

  5. Clinical Trials Report for May 2015

    ... We have highlighted some clinical trials currently recruiting patients. Each has a specific purpose ... Intermediate Risk Disease The goal of this research study is to test a quality-of-life questionnaire called QUALMS-1 in ...

    Page last updated 04/28/2015 - 11:38am.

  6. Clofarabine in the treatment of myelodysplastic syndromes

    ... patients with MDS and acute myeloid leukemia (AML).  Early research studies identified 40 mg/m2 daily for 5 days per course as the ... cell transplantation in patients with MDS. Additional clinical trials are needed to define which patients derive the most benefit ...

    Research Review last updated 05/02/2016 - 9:18am.

  7. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s ... the patient, in the opinion of the PI or LAI, will meet the research phase eligibility criteria and proceed to transplant after induction ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  8. Transplants With Unlicensed Preserved Cord Blood

    For more details on this clinical trial, including contact information, please see this trial’s ... transplantation if the transplant will occur under an IND research protocol . These units are in current and future inventory at ...

    Clinical Trial last updated 04/27/2016 - 3:20pm.

  9. Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

    For more details on this clinical trial, including contact information, please see this trial’s ... HLA-matched unrelated donor (Fred Hutchinson Cancer Research Center [FHCRC] matching allowed will be Grade 1.0 to 2.1) is available ...

    Clinical Trial last updated 04/28/2016 - 2:45pm.

  10. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    For more details on this clinical trial, including contact information, please see this trial’s ... ) Each patient must be willing to participate as a research subject and must sign an informed consent form. Donor Inclusion ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.